From structural tailwind to defense tech venture capital bubble 2026 risk
Defense technology funding has entered a new phase, with talk of a potential defense tech venture capital bubble 2026 fueled by headline numbers rather than careful context. According to aggregated estimates from PitchBook Data and CB Insights, global defense and dual-use startups raised roughly $14.6 billion in the first five months of 2025, while preliminary Q1 2026 figures point to an annualized run rate of around $19.8 billion across more than 250 deals. That pace already eclipses the prior full-year record of about $9.6 billion in 2023 and forces CEOs and allocators to ask whether this is a durable repricing of national security technology or a classic late-cycle boom in a newly fashionable asset class. The core question is whether defense tech and military AI are now a structural part of national security infrastructure or simply the latest sector where too much capital chases too few companies.
The structural case is real, because NATO defense budgets are rising and procurement is shifting toward software-centric products and services from agile startups rather than only legacy defense contractors. NATO members have collectively added more than $100 billion in annual defense spending since 2020, and U.S. Department of Defense budget documents show software, cyber, and R&D lines growing faster than traditional hardware. Pentagon buyers now run more open competitions where smaller defense technology companies can win deals against primes, and that change in how defense capital is allocated is unlikely to reverse in a year or two. For CEOs, the signal is that defense is no longer a niche government contracting backwater but a mainstream tech market where venture investors expect both growth and resilience through geopolitical cycles.
Yet the speed of the capital surge raises a sharper question about whether we are watching a defense-focused venture bubble form in real time. Early-stage defense startups now command 17 to 50 times revenue multiples, which is aggressive for companies with long sales cycles, lumpy government contracts, and products and services that must pass stringent testing before deployment. Studies of U.S. defense procurement suggest that the average sales cycle from first pilot to program of record can run three to seven years, and only a minority of pilots convert into multi-year contracts. In this environment, some investors will inevitably say they did not invest early enough, while others will quietly admit they lost money because their investment committee underwrote defense software as if it were consumer SaaS rather than a regulated national security domain.
Anduril sits at the center of this shift, with its reported $5 billion Series H valuing the company at roughly $30.5 billion and anchoring the perception that technology going into defense can scale like mainstream Silicon Valley platforms. Public reports also cite Shield AI’s approximately $2 billion Series G and Saronic’s roughly $1.75 billion Series D, reinforcing the idea that individual defense tech companies can absorb billion-dollar checks and still show venture-style growth. When a single company is valued billion after billion in successive rounds, allocators must ask whether patient capital is underwriting long-term national security outcomes or simply extrapolating the success Palantir had in public markets into every new defense startup.
The concentration risk is obvious when a handful of companies dominate the defense tech cap table and headline numbers. Anduril, Shield AI, and Saronic together represent a large share of the recent billion-dollar funding wave, which means the narrative about a potential defense tech venture capital bubble 2026 is being shaped by a very narrow slice of the market. For CEOs running smaller defense companies or adjacent dual-use startups, this concentration can distort expectations about valuation, capital intensity, and how long it really takes to win material contracts with government buyers.
Traditional venture capital firms such as Kleiner Perkins and Advent entering defense technology signal that mainstream capital now treats national security as a core tech theme rather than a specialist niche. That shift will change deal terms, board dynamics, and the way companies are pushed to grow, because generalist investors often assume that technology requires rapid scaling even when the valley of death between prototype and program of record can last years. For allocators reading Fortune coverage or PitchBook Data summaries of the sector, the key is to separate structural defense demand from cyclical venture exuberance before the bubble narrative hardens into a self-fulfilling prophecy.
To ground that distinction, CEOs and investment committees can track a few simple metrics drawn from recent defense tech deal flow and procurement studies:
- Annual deal count in defense and dual-use startups versus prior cycles
- Estimated pilot-to-program conversion rate (often well below 50 percent)
- Median time from first pilot to initial production contract (frequently three to seven years)
- Share of total capital captured by the top five defense tech companies in a given year
Valuations, exits, and the awkward teenage years of military AI
Valuation discipline is often the first casualty when a sector sprints from roughly $9.6 billion in a prior year to more than $14.6 billion in just a few months, and defense technology is no exception. Early-stage startups trading at 17 to 50 times revenue may look justified when contracts ramp, but those multiples embed heroic assumptions about how fast companies can win deals and convert pilots into long-term programs. Industry surveys suggest that fewer than one in three early pilots ever become full-scale deployments, which makes those valuation levels particularly fragile. For CEOs, the question is whether to lean into this frothy pricing environment or deliberately raise less capital to preserve strategic flexibility when the market normalizes.
The Swarmer IPO, with its more than 500 percent opening-day pop as reported in SEC filings and financial press coverage, is being treated as proof that defense tech can exit through public markets rather than relying only on M&A by primes. That single company outcome, however, does not change the reality that most defense companies still exit through strategic acquisitions, often after long periods of patient capital support and years of grinding through procurement cycles. Historical exit data from aerospace and defense transactions shows that the majority of startups sell to primes or large industrials at single- to low-double-digit revenue multiples. If allocators underwrite every defense tech investment as another Swarmer or another Palantir-style success story, they will almost certainly be disappointed by the distribution of returns.
Defense technology is entering what one Fortune analysis called its awkward teenage years, where there are real companies, real revenue, and real national security impact, but also real froth and uneven governance. In this phase, some investors will say they did not invest because the sector felt too political, while others will quietly acknowledge that they did not fully understand how long defense sales take or how often early pilots are loss leaders. CEOs should treat this period as a stress test of their capital strategy, not a validation that every company in the space deserves a billion-dollar valuation label.
Anduril CEO Brian Schimpf has been explicit about the risks, warning that when there are successful companies, you have lots of other companies and investors chasing that with very risky behavior. That comment cuts through the marketing narrative and forces a direct question for any company going to market for a new round in this overheated defense funding environment. Are you raising to accelerate a validated go-to-market motion, or are you raising because the market is temporarily willing to pay a premium for anything labeled defense tech or military AI?
Traditional VCs from Silicon Valley, who cut their teeth on consumer and enterprise software, often underestimate how long defense procurement takes and how much patient capital is required before a program of record lands. National security technology requires iterative testing, integration with legacy systems, and security accreditation, which means that even strong products and services can sit in the valley of death between prototype and scaled deployment for years. For a deeper comparison, CEOs can look at how biotech venture cycles handled large rounds without forming a bubble, as analyzed in this piece on why the very large biotech rounds are not necessarily a bubble.
Exit pathways will define whether the defense tech bubble label sticks or fades, because a handful of IPOs cannot carry a whole asset class. Most companies in this arena will still rely on M&A, often selling to primes or large tech companies that want to deepen their national security footprint, and those deals rarely clear at 50 times revenue. CEOs should model scenarios where their company going public is unlikely and instead focus on building products, services, and data moats that make them indispensable acquisition targets rather than optional bolt-ons.
How CEOs and allocators should underwrite defense tech in a frothy cycle
For CEOs and capital allocators, the practical question is how to participate in defense technology upside without being trapped in a painful unwind if today’s enthusiasm proves to be a defense tech venture capital bubble 2026. The first step is to treat defense as an infrastructure category tied to national security outcomes, not as a short-term momentum trade driven by headline deals and billion-dollar rounds. That means underwriting companies on the basis of mission-critical products and services, validated demand signals from government buyers, and evidence that they can repeatedly win competitions against both primes and other startups.
Data discipline matters more than ever, because noisy PitchBook charts and Fortune headlines can obscure the underlying distribution of returns across defense tech companies. CEOs should track not only how much capital is flowing into the sector each year, but also how many companies actually convert pilots into multi-year contracts and how many quietly stall in the valley of death. Allocators should ask where investors have already lost money in defense tech, where they did not invest despite strong signals, and where they failed to fully price in regulatory, export control, or classification risk.
Portfolio construction in this environment should look more like infrastructure or credit than classic Silicon Valley spray-and-pray venture capital. A concentrated set of high-conviction positions in companies with clear national security missions, strong data advantages, and credible paths to profitability will usually outperform a broad basket of lightly underwritten defense tech startups. For a useful parallel on how generalist VCs entered another capital-intensive theme, see this analysis of why generalist funds moved into the second wave of climate tech and how that reshaped deal terms.
Strategic acquirers are already repositioning, as shown by transactions like the Oaktree Capital Management acquisition of Rand Logistics, which offers a template for how CEOs should read strategic logistics and defense-adjacent deals. Those transactions highlight that patient capital can back companies for many years before a liquidity event, and that the real fortune is often made in the quiet middle years rather than at the headline-making IPO. For defense tech founders, the lesson is to design cap tables and governance structures that can survive long development cycles and shifting geopolitical priorities.
Public narratives around defense technology are also shifting, with commentators such as Pete Hegseth framing military AI as essential to national security while journalists like Allie Garfinkle at Fortune dissect whether the sector is entering an awkward teenage phase. That tension between patriotic framing and market skepticism will influence how both retail and institutional investors view rising defense budgets and the companies that seek to serve them. CEOs must be ready to explain not only how their technology improves outcomes, but also how their company manages ethical, regulatory, and geopolitical risk over many years.
In this cycle, the most resilient defense companies will be those that treat capital as a strategic weapon rather than a vanity metric. They will raise when the market is open but structure rounds to preserve control, avoid unnecessary dilution, and align with investors who understand that complex technology requires time, testing, and patient capital before it can reshape national security architectures. For both founders and allocators, the real power in defense tech is not the term sheet, but the power it encodes in who controls the company, the mission, and the data that will define the next decades of military AI.